Pharmaceutical Investing KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
Pharmaceutical Investing KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
RETRANSMISSION: Group Eleven to be Featured on Radius Research for a Live Company Pitch, Deep Dive and Q&A Webinar
Freegold Reports Final 2024 Drilling Results from Golden Summit Continuing to Confirm Higher Grade Potential